TMN-16988-27536
3 vaccinations
1 coded response
19 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 441 / OH
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Registered dependents
QYL-26633-53387
Child or adolescent in my care · Female · 2022-06-30
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Moderna
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-13
- 2021-01-18
- 2021-01-25
-
2021-01-26
Dose 2 — Moderna
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-07-27
-
2021-10-21
Dose 3 — ModernaCo-administered: Flu
-
2021-10-25
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Axillary lymphadenopathy in injected arm - improvingMedDRA releases: 2024-11 · check-in free text available
- 2021-10-28
- 2022-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-26 | Moderna | |
| 3 | 2021-10-21 | Moderna | Flu |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Axillary lymphadenopathy in injected arm - improving
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release